Pfizer, a once-shining beacon of the pharmaceutical industry, has seen its stock tumble considerably since its pandemic-fueled highs. With shares down over 50% from their 2021 peak, many investors are scratching their heads. What was once a darling of Wall Street now rests near a critical 10-year support level. The question on everyone’s mind: is … Pfizer at Crucial Price Support: Time to Buy the Dip or a Sign of Deeper Trouble?
The post Pfizer at Crucial Price Support: Time to Buy the Dip or a Sign of Deeper Trouble? appeared first on ImaStockTrader.